AR is expressed in multiple tissues, and it is positively correlated with six integrin genes in PRAD and also with other integrin genes in other cancer types (e.g., HNSC and CESC), indicating a weak cancer type specificity. The gene discussed is AR; the disease is prostate adenocarcinoma.